Navigation Links
FDA Confirms No Heart Risk From Heartburn Drugs
Date:12/10/2007

were designed to test the effectiveness of the drugs, compared with surgery, for severe gastroesophageal reflux disease (GERD).

During the trials, some cardiac "events" were seen among study participants, hinting that long-term use of Prilosec and Nexium could increase the risk of heart attack, heart failure and heart-related sudden death, the FDA said at the time.

Because of these concerns, AstraZeneca gave the FDA more detailed data from the two initial studies as well as findings from 14 other studies -- one 14 years in length -- that compared the drugs with a placebo.

The more complete data showed that patients taking Prilosec had a lower risk of heart problems than patients taking a placebo. And findings from the ongoing Nexium trial found no difference in heart problems between patients taking the drug and those undergoing surgery for GERD, the FDA statement said.

In a prepared statement released Monday, AstraZeneca said it "supports the conclusion made by the FDA that the overall benefit/risk profiles of omeprazole (Prilosec) and Nexium remain unchanged. AstraZeneca continues to be confident in the safety profiles of omeprazole and Nexium."

However, Seligman did say that the FDA continues to investigate whether the drugs increase the risk of hip fracture. A report in the Dec. 27, 2006, issue of the Journal of the American Medical Association found that people 50 and older who took Prilosec or Nexium had a 44 percent higher risk of hip fracture than people not taking these drugs.

Prilosec and Nexium are drugs known as proton pump inhibitors, which treat the symptoms of GERD and other conditions caused by excess stomach acid.

AstraZeneca says more than 1 billion patients worldwide take the drugs, according to Bloomberg News.

Prilosec is also available over-the-counter to treat frequent heartburn.

More information

For more on GERD, visit the
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
2. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
3. Actavis Confirms its Patent Challenge of Kings Avinza(R)
4. Barr Confirms Patent Challenge of UROXATRAL(R)
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms
7. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
8. LUNA Pure Prevention Survey Confirms Breast Cancer Misconceptions
9. Barr Confirms Patent Challenge of Ritalin(R) LA
10. New Research Released at AHA Confirms Itamars PAT Technology to Diagnose Early Cardiovascular Disease
11. Survey Confirms Americans Have a True Blind Spot Regarding Their Eye Health - and the Real Danger of UV Rays
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Confirms No Heart Risk From Heartburn Drugs
(Date:8/28/2014)... (PRWEB) August 28, 2014 After more ... Paul Vitenas is excited to announce the opening ... its kind in any city, Mirror Mirror Beauty Boutique ... , Situated on the corner of Richmond and Drexel ... architecture, luxurious amenities, and cutting-edge technology in a private, ...
(Date:8/28/2014)... THURSDAY, Aug. 28, 2014 (HealthDay News) -- Having greater ... your ability to see distant objects in hazy conditions, ... University of Georgia researchers simulated hazy conditions in order ... levels of yellow pigment (also called macular pigment) in ... of yellow pigment, which represents accumulations of the nutrients ...
(Date:8/28/2014)... 2014 The Foundation for Women’s ... in September by alerting women to the link between ... the symptoms of endometrial cancer. , Endometrial cancer ... most common cancer. More than 52,600 will learn of ... for women with weight management challenges to know the ...
(Date:8/28/2014)... Vitals, a recognized and trusted website for ... Cosmetic Laser Dermatology one of their Top 10 Doctors ... to share their doctor experiences and rate their doctors on ... follow-ups. The Vitals Top 10 Doctor recognition means that out ... one of the highest by patients. , “I’m honored to ...
(Date:8/28/2014)... August 28, 2014 Dr. Bryan McIntosh ... downloadable ebook guide to the tummy tuck cosmetic ... surgery, the procedure itself, and how to recover well ... candid explanations. Dr. McIntosh also discusses how to have ... ensure that the procedure is as successful as possible. ...
Breaking Medicine News(10 mins):Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Foundation for Women's Cancer Alerts Women to Link Between Obesity and Endometrial Cancer 2Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:The Ultimate Guide to the Tummy Tuck Surgery eBook is Released by Dr. Bryan McIntosh 2
... U.S. HIV/AIDS Atlas , , WASHINGTON, June 22 ... Atlas ( http://www.MapHIV.org ) that highlights ... United States. The Atlas makes information on HIV/AIDS prevalence ... painting a comprehensive picture of the varying intensity of the ...
... Hoag ... of Cardiology) as its executive medical director of the Hoag Heart and Vascular Institute (HHVI). ... Newport Beach, Calif. ... Tancredi, M.D., F.A.C.C. (Fellow of the American College of Cardiology) as its executive medical director ...
... Time for Fitness! , , LOS ANGELES, June 22 ... the park or along the beach. Now a brand new product ... equipment on wheels, but with a unique design to allow your ... new concept of fitness, will be introduced to California starting from ...
... study finds, , MONDAY, June 22 (HealthDay News) -- ... blood pressure, but new research finds those extra pounds can ... especially if she experiences early menopause. , Published in the ... found that women with a body-mass index (BMI) greater than ...
... CRO expertise in $1 billion market for cancer support ... , WATERTOWN, Mass., June 22 Biomodels LLC, ... today announced that its customized research program allowed ActoGeniX ... Food and Drug Administration (FDA) approval for Phase 1b ...
... LLC, the rising star of the Sports Nutrition Industry, ... each of Vitamin Shoppe,s 400+ locations nationwide. , ... of our entire line of products," MUSCLEPHARM president Brad ... in nearly every neighborhood across the nation! Vitamin Shoppe ...
Cached Medicine News:Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 2Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 3Health News:Nationally Acclaimed Cardiologist Joins Hoag Heart and Vascular Institute as Executive Medical Director 2Health News:Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 2Health News:Obesity Greatly Raises Endometrial Cancer Risk 2Health News:Obesity Greatly Raises Endometrial Cancer Risk 3Health News:Biomodels' Oral Mucositis Expertise Speeds FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients 2Health News:MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang! 2
(Date:8/28/2014)... , Aug. 28, 2014 MGC Diagnostics Corporation ... a conference call to discuss its financial results for ... 2014. The call will be at 4:30 p.m. ET ... financial results for the third quarter of fiscal 2014 ... Participants can dial (877) 317-6789 or ...
(Date:8/28/2014)... SAN ANTONIO , Aug. 28, 2014 ... therapeutics for the treatment of cancer, announces the recent ... the journal Steroids . The recent ... below), reviews the evolution and development of GenSpera,s prodrug technology ... activity of thapsigargin (from the plant Thapsia garganica ...
(Date:8/28/2014)... 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... data from trials evaluating the use of collagenase clostridium histolyticum ... adult patients with a palpable cord will be presented at ... Society for Surgery of the Hand (ASSH) being held in ... ® (CCH) is a biologic approved in the U.S., ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Third Quarter Fiscal 2014 Financial Results on Tuesday, September 9, 2014 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 6
... Cognizant (NASDAQ: CTSH ), a ... outsourcing services, today announced a multi-year agreement with ... services to generate clinical study reports. ... statistical programming, statistical analysis, medical writing, and document ...
... 29, 2011  Buffalo Heart Group, LLP, 2011 :  Today ... of the AngelMed Guardian cardiac monitor and alert system. The ... to get to the emergency room during an impending heart ... state of New York, and is among the very first ...
Cached Medicine Technology:Cognizant to Deliver Comprehensive Biostatistics and Medical Reporting Services for AstraZeneca 2Cognizant to Deliver Comprehensive Biostatistics and Medical Reporting Services for AstraZeneca 3Buffalo Heart Group Investigates Early Heart Attack Detection Device Developed By Angel Medical Systems 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: